A recent paper showed that the BMP4 signaling pathway promotes trans-differentiation of tumor cells in relapsed medulloblastoma, supporting the argument that this pathway could acts in maintaining the CSC pool in both primary and relapsed tumors [55]. The gene discussed is BMP4; the disease is medulloblastoma.